Cologne Cohort of Neutropenic Patients (CoCoNut)

NCT01821456 · tracked via the Priya Life Science Germany tracker

Sponsor

University Hospital of Cologne

Phase

Observational

Started

1995-01

Last updated

2013-04-01

Condition(s) studied

Hematological MalignanciesCancerChemotherapyNeutropeniaImmunosuppression

Investigational drug(s) / intervention(s)

Antiinfectives

Antiinfectives: To analyze to efficacy of (novel) drug therapies

Study summary

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

Eligibility

Sex

ALL

Min age

1 Year

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: * immunosuppressed patients Exclusion Criteria: * none

Primary outcome measure(s)

Long-term survival of hematology and oncology patients following neutropenia — 2 years following last follow-up

Trial sites (1)

Facility	City	Region	Status
University Hospital of Cologne	Cologne	North Rhine-Westphalia	Recruiting

More University Hospital of Cologne trials in Germany

Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support Recruiting

Preoperative Physical Exercise, Nutritional Support, and Psychological Intervention (Multimodal Prehabilitation) to Strengthen Patients' Overall Health and Reduce Postoperative Complications Starting soon

Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/or <1500 g Birth Weight Recruiting

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR) Recruiting

Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment Starting soon

Other trials for the same condition

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases Recruiting

Pan Tumor Rollover Study Recruiting

Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries. Recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor Active, not recruiting

Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01821456 on ClinicalTrials.gov ↗ ← All trials in Germany